| Id |
Subject |
Object |
Predicate |
Lexical cue |
| TextSentencer_T1 |
0-92 |
Sentence |
denotes |
Development and characterization of monoclonal antibodies against a mucin-type glycoprotein. |
| T1 |
0-92 |
Sentence |
denotes |
Development and characterization of monoclonal antibodies against a mucin-type glycoprotein. |
| T1 |
0-92 |
Sentence |
denotes |
Development and characterization of monoclonal antibodies against a mucin-type glycoprotein. |
| TextSentencer_T2 |
93-298 |
Sentence |
denotes |
The preparation of greater than 30 different hybridomas, all secreting IgM class antibodies against epiglycanin, a glycoprotein at the surface of the mouse mammary carcinoma cell line TA3-Ha, is described. |
| T2 |
93-298 |
Sentence |
denotes |
The preparation of greater than 30 different hybridomas, all secreting IgM class antibodies against epiglycanin, a glycoprotein at the surface of the mouse mammary carcinoma cell line TA3-Ha, is described. |
| T2 |
93-298 |
Sentence |
denotes |
The preparation of greater than 30 different hybridomas, all secreting IgM class antibodies against epiglycanin, a glycoprotein at the surface of the mouse mammary carcinoma cell line TA3-Ha, is described. |
| TextSentencer_T3 |
299-454 |
Sentence |
denotes |
The specificities of 10 of the antibodies, with affinity constants in the range of 10(8)-10(10) l/mol were compared in an enzyme competitive binding assay. |
| T3 |
299-454 |
Sentence |
denotes |
The specificities of 10 of the antibodies, with affinity constants in the range of 10(8)-10(10) l/mol were compared in an enzyme competitive binding assay. |
| T3 |
299-454 |
Sentence |
denotes |
The specificities of 10 of the antibodies, with affinity constants in the range of 10(8)-10(10) l/mol were compared in an enzyme competitive binding assay. |
| TextSentencer_T4 |
455-667 |
Sentence |
denotes |
The affinity of epiglycanin was strongly reduced for all antibodies tested by incubation with periodate (10 mM, 4 degrees C) and was reduced for most of the antibodies by endo-alpha-N-acetyl- D-galactosaminidase. |
| T4 |
455-667 |
Sentence |
denotes |
The affinity of epiglycanin was strongly reduced for all antibodies tested by incubation with periodate (10 mM, 4 degrees C) and was reduced for most of the antibodies by endo-alpha-N-acetyl- D-galactosaminidase. |
| T4 |
455-667 |
Sentence |
denotes |
The affinity of epiglycanin was strongly reduced for all antibodies tested by incubation with periodate (10 mM, 4 degrees C) and was reduced for most of the antibodies by endo-alpha-N-acetyl- D-galactosaminidase. |
| TextSentencer_T5 |
668-827 |
Sentence |
denotes |
This suggested that carbohydrate, and specifically the Gal beta (1----3)GalNAc disaccharide, formed an integral part of the epitopes of most of the antibodies. |
| T5 |
668-827 |
Sentence |
denotes |
This suggested that carbohydrate, and specifically the Gal beta (1----3)GalNAc disaccharide, formed an integral part of the epitopes of most of the antibodies. |
| T5 |
668-827 |
Sentence |
denotes |
This suggested that carbohydrate, and specifically the Gal beta (1----3)GalNAc disaccharide, formed an integral part of the epitopes of most of the antibodies. |
| TextSentencer_T6 |
828-963 |
Sentence |
denotes |
The isolated disaccharide, however, exhibited 250,000 times less inhibitory activity in the competitive binding assay than epiglycanin. |
| T6 |
828-963 |
Sentence |
denotes |
The isolated disaccharide, however, exhibited 250,000 times less inhibitory activity in the competitive binding assay than epiglycanin. |
| T6 |
828-963 |
Sentence |
denotes |
The isolated disaccharide, however, exhibited 250,000 times less inhibitory activity in the competitive binding assay than epiglycanin. |
| TextSentencer_T7 |
964-1114 |
Sentence |
denotes |
The binding capacity of epiglycanin was also reduced by incubation with trypsin or pronase, suggesting a high molecular weight dependency for binding. |
| T7 |
964-1114 |
Sentence |
denotes |
The binding capacity of epiglycanin was also reduced by incubation with trypsin or pronase, suggesting a high molecular weight dependency for binding. |
| T7 |
964-1114 |
Sentence |
denotes |
The binding capacity of epiglycanin was also reduced by incubation with trypsin or pronase, suggesting a high molecular weight dependency for binding. |
| TextSentencer_T8 |
1115-1183 |
Sentence |
denotes |
Incubation with sialidase increased its affinity for the antibodies. |
| T8 |
1115-1183 |
Sentence |
denotes |
Incubation with sialidase increased its affinity for the antibodies. |
| T8 |
1115-1183 |
Sentence |
denotes |
Incubation with sialidase increased its affinity for the antibodies. |
| TextSentencer_T9 |
1184-1387 |
Sentence |
denotes |
The binding of the antibodies to epiglycanin was strongly inhibited by peanut agglutinin, and to a lesser extent by lectins from Triticum vulgaris, Ricinus communis, Pisum sativum and Phaseolus vulgaris. |
| T9 |
1184-1387 |
Sentence |
denotes |
The binding of the antibodies to epiglycanin was strongly inhibited by peanut agglutinin, and to a lesser extent by lectins from Triticum vulgaris, Ricinus communis, Pisum sativum and Phaseolus vulgaris. |
| T9 |
1184-1387 |
Sentence |
denotes |
The binding of the antibodies to epiglycanin was strongly inhibited by peanut agglutinin, and to a lesser extent by lectins from Triticum vulgaris, Ricinus communis, Pisum sativum and Phaseolus vulgaris. |
| TextSentencer_T10 |
1388-1484 |
Sentence |
denotes |
None of the antibodies bound to any of eight different gangliosides immobilized on HPTLC plates. |
| T10 |
1388-1484 |
Sentence |
denotes |
None of the antibodies bound to any of eight different gangliosides immobilized on HPTLC plates. |
| T10 |
1388-1484 |
Sentence |
denotes |
None of the antibodies bound to any of eight different gangliosides immobilized on HPTLC plates. |
| TextSentencer_T11 |
1485-1592 |
Sentence |
denotes |
Mono- (Fab) and divalent [F(ab')2] fragments of the antibodies possessed very low affinity for epiglycanin. |
| T11 |
1485-1592 |
Sentence |
denotes |
Mono- (Fab) and divalent [F(ab')2] fragments of the antibodies possessed very low affinity for epiglycanin. |
| T11 |
1485-1592 |
Sentence |
denotes |
Mono- (Fab) and divalent [F(ab')2] fragments of the antibodies possessed very low affinity for epiglycanin. |
| TextSentencer_T12 |
1593-1865 |
Sentence |
denotes |
The results demonstrated that the specificities of the antibodies are related, but distinguishable, and they suggest that this epiglycanin-IgM model may be useful for studies on the general principles of the interaction between IgM antibodies and mucin-type glycoproteins. |
| T12 |
1593-1865 |
Sentence |
denotes |
The results demonstrated that the specificities of the antibodies are related, but distinguishable, and they suggest that this epiglycanin-IgM model may be useful for studies on the general principles of the interaction between IgM antibodies and mucin-type glycoproteins. |
| T12 |
1593-1865 |
Sentence |
denotes |
The results demonstrated that the specificities of the antibodies are related, but distinguishable, and they suggest that this epiglycanin-IgM model may be useful for studies on the general principles of the interaction between IgM antibodies and mucin-type glycoproteins. |